Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1995-4-27
pubmed:abstractText
Available contraceptive implants appeal to women of diverse cultural and socioeconomic background because they offer long-term contraception, safety, effectiveness, reversibility and lack of estrogenic side-effects. Experience with Norplant I indicates that despite some side-effects the continuation rate is the highest for any reversible method of contraception. Disruption of the menstrual cycle is the main reason for discontinuation, hence research effort needs to focus on the mechanism of progestogen-induced endometrial bleeding and appropriate therapy. Implant service programs should have trained and skilled personnel who can provide adequate counseling that complements any public education effort and also provides effective services. Because contraceptive implants offer no protection against sexually transmitted infections, those who engage in high-risk sexual behavior should be encouraged to use condoms as well.
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Biology, http://linkedlifedata.com/resource/pubmed/keyword/Bleeding, http://linkedlifedata.com/resource/pubmed/keyword/Contraception, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Implants, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods, http://linkedlifedata.com/resource/pubmed/keyword/Diseases, http://linkedlifedata.com/resource/pubmed/keyword/Endometrial Effects, http://linkedlifedata.com/resource/pubmed/keyword/Endometrium, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, Female, http://linkedlifedata.com/resource/pubmed/keyword/Literature Review, http://linkedlifedata.com/resource/pubmed/keyword/Menstruation Disorders, http://linkedlifedata.com/resource/pubmed/keyword/Physiology, http://linkedlifedata.com/resource/pubmed/keyword/Reversibility, http://linkedlifedata.com/resource/pubmed/keyword/Signs And Symptoms, http://linkedlifedata.com/resource/pubmed/keyword/Urogenital System, http://linkedlifedata.com/resource/pubmed/keyword/Uterus
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1040-872X
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
564-9
pubmed:dateRevised
2004-11-17
pubmed:otherAbstract
PIP: Women of diverse cultural and socioeconomic levels choose available contraceptive implants because of long-term contraception, safety, effectiveness, reversibility, and lack of estrogenic side effects. Norplant is a safe, effective method of reversible fertility regulation, as shown by studies in several countries with diverse sociocultural and demographic profiles. However, the major shortcoming is menstrual disorders, which cause about half of all discontinuations. Since the US Food and Drug Administration approved the use of Norplant in December 1990, acceptability among the diverse general population was largely dependent on the intensity of counseling. Removal rates of Norplant implants in adolescents were similar to those for mature women, and in general implant acceptability, continuation, and tolerance of side effects were high and comparable among adolescent and adult acceptors. Abnormal bleeding patterns still represent the most common complaint and reason for discontinuation among adolescents and adults. The insertion and removal of Norplant requires appropriate training of physicians and nonphysicians who plan to provide Norplant services. Norplant II consists of 2 silastic rods each containing 70 mg levonorgestrel. Phase III clinical trials in 1466 Indian women observed for 52,849 woman-months of use resulted in a method failure rate of 6.8 per 100 users and a continuation rate of 42.1 per 100 users at 5 years of use. Nomegestrol acetate implant is a second-generation single silastic implant containing 55 mg nomegestrol acetate with contraceptive effectiveness of 1-year duration. Implanon implant is a single ethylene vinyl acetate rod containing 60 mg 3-ketodesogestrel with more progestogenic and less androgenic activity than levonorgestrel and 2-year effectiveness. ST-1435 implant contains ST-1435, a synthetic progestin which inhibits ovulation when administered parenterally but not orally. If appropriate counseling is provided implants can be a popular method of contraception in different parts of the world.
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Contraceptive implants.
pubmed:affiliation
South to South Cooperation in Reproductive Health, Salvador, Bahia, Brazil.
pubmed:publicationType
Journal Article